Literature DB >> 19766240

Do ameroid constrictors reliably occlude porcine coronary arteries?

Jeremy L Herrmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19766240      PMCID： PMC2862819          DOI： 10.1016/j.jss.2009.05.047

Source DB:  PubMed          Journal:  J Surg Res        ISSN： 0022-4804            Impact factor:   2.192


× No keyword cloud information.
  8 in total

1.  Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy.

Authors:  H E Bøtker; J F Lassen; F Hermansen; H Wiggers; P Søgaard; W Y Kim; M Bøttcher; L Thuesen; A K Pedersen
Journal:  Circulation       Date:  2001-03-27       Impact factor: 29.690

2.  The experimental production of coronary artery insufficiency and occlusion.

Authors:  J LITVAK; L E SIDERIDES; A M VINEBERG
Journal:  Am Heart J       Date:  1957-04       Impact factor: 4.749

3.  NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A-165 in patients with chronic myocardial ischemia: subanalysis of the EUROINJECT-ONE multicenter double-blind randomized study.

Authors:  Mariann Gyöngyösi; Aliasghar Khorsand; Sholeh Zamini; Wolfgang Sperker; Christoph Strehblow; Jens Kastrup; Eric Jorgensen; Birger Hesse; Kristina Tägil; Hans Erik Bøtker; Witold Ruzyllo; Anna Teresiñska; Dariusz Dudek; Alicja Hubalewska; Andreas Rück; Søren Steen Nielsen; Senta Graf; Gerald Mundigler; Jacek Novak; Heinz Sochor; Gerald Maurer; Dietmar Glogar; Christer Sylven
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

4.  Correlation of ischemic area and coronary flow with ameroid size in a porcine model.

Authors:  Egemen Tuzun; Eddie Oliveira; Cuneyt Narin; Hassan Khalil; Pilar Jimenez-Quevedo; Emerson Perin; Guilherme Silva
Journal:  J Surg Res       Date:  2009-04-19       Impact factor: 2.192

5.  Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.

Authors:  Douglas W Losordo; Peter R Vale; Robert C Hendel; Charles E Milliken; F David Fortuin; Nancie Cummings; Richard A Schatz; Takayuki Asahara; Jeffrey M Isner; Richard E Kuntz
Journal:  Circulation       Date:  2002-04-30       Impact factor: 29.690

6.  Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure.

Authors:  Emerson C Perin; Hans F R Dohmann; Radovan Borojevic; Suzana A Silva; Andre L S Sousa; Claudio T Mesquita; Maria I D Rossi; Antonio C Carvalho; Helio S Dutra; Hans J F Dohmann; Guilherme V Silva; Luciano Belém; Ricardo Vivacqua; Fernando O D Rangel; Roberto Esporcatte; Yong J Geng; William K Vaughn; Joao A R Assad; Evandro T Mesquita; James T Willerson
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

7.  Quantification of collateral resistance in acute and chronic experimental coronary occlusion in the dog.

Authors:  W Schaper; W Flameng; B Winkler; B Wüsten; W Türschmann; G Neugebauer; M Carl; S Pasyk
Journal:  Circ Res       Date:  1976-09       Impact factor: 17.367

8.  Spatial heterogeneity of endocardial voltage amplitude in viable, chronically dysfunctional myocardium.

Authors:  James A Fallavollita; Uma Valeti; Sameer Oza; John M Canty
Journal:  Basic Res Cardiol       Date:  2004-02-13       Impact factor: 17.165
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.